FDA Approves Supplement for HETLIOZ (Tasimelteon) by Vanda Pharmaceuticals
The FDA has approved a supplemental application for HETLIOZ, a drug containing tasimelteon.
Indication
Clinical and regulatory intelligence for Sleep Disorders with 13 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.